Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Patients During a Blood Draw
Launched by ZYNEX MONITORING SOLUTIONS · Apr 30, 2013
Trial Information
Current as of May 30, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy volunteers
- • Between 18-35 years of age
- • Weight between 130-200 pounds
- Exclusion Criteria:
- • Known cardiac disease
- • Recent caffeine intake
- • Tobacco use in the (4) hours prior to screening
- • Infection
- • Pregnancy
- • Hemoglobin \<13.5 g/dl
About Zynex Monitoring Solutions
Zynex Monitoring Solutions is a pioneering clinical trial sponsor dedicated to advancing patient care through innovative monitoring technologies. With a focus on developing cutting-edge medical devices and software solutions, Zynex enhances the accuracy and efficiency of patient monitoring in clinical settings. The organization is committed to rigorous research and development, ensuring that its products meet the highest standards of safety and efficacy. By facilitating seamless integration of advanced monitoring systems, Zynex aims to improve patient outcomes and streamline clinical workflows, ultimately contributing to the evolution of healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salt Lake City, Utah, United States
Patients applied
Trial Officials
John Ziegler, MD
Principal Investigator
Premier Research Group plc
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials